Status:
COMPLETED
PrEP Among MSM and TG in Myanmar
Lead Sponsor:
Myanmar Oxford Clinical Research Unit
Collaborating Sponsors:
Medical Action Myanmar
Institute of Tropical Medicine, Belgium
Conditions:
HIV Infections
Eligibility:
All Genders
Brief Summary
HIV is concentrated among key populations in Myanmar. Globally, HIV-prevalence among transgender (TG) women is one of the highest; laboratory-confirmed prevalence is reported up to 40%. In September 2...
Eligibility Criteria
Inclusion
- HIV-negative
- No suspicion of acute HIV infection
- Substantial risk of HIV infection
- Creatinine clearance is more than 30 ml/min
- Willingness to use PrEP as prescribed, including periodic HIV testing
- Willingness to sign informed consent
Exclusion
- • Anyone who is not eligible with the inclusion criteria
Key Trial Info
Start Date :
October 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04781426
Start Date
October 28 2020
End Date
August 31 2021
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Action Myanmar Clinics
Yangon, Burma